Asia Pacific Neurological Biomarkers Market Size, Trends, 2028

Asia Pacific Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report By Type (Proteomic, Genomic, Metabolomic), By Application (Alzheimer's Disease, Parkinson’s Disease and Multiple Sclerosis), By Country and Growth Forecast, 2022 - 2028

Published Date: October-2022 | Number of Pages: 75 | Format: PDF | Report ID: KBV-20996

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Neurological Biomarkers Market, by Type
1.4.2 Asia Pacific Neurological Biomarkers Market, by Application
1.4.3 Asia Pacific Neurological Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Neurological Biomarkers Market by Type
3.1 Asia Pacific Proteomic Market by Country
3.2 Asia Pacific Genomic Market by Country
3.3 Asia Pacific Metabolomic Market by Country
3.4 Asia Pacific Others Market by Country

Chapter 4. Asia Pacific Neurological Biomarkers Market by Application
4.1 Asia Pacific Alzheimer's Disease Market by Country
4.2 Asia Pacific Parkinson’s Disease Market by Country
4.3 Asia Pacific Multiple Sclerosis Market by Country

Chapter 5. Asia Pacific Neurological Biomarkers Market by Country
5.1 China Neurological Biomarkers Market
5.1.1 China Neurological Biomarkers Market by Type
5.1.2 China Neurological Biomarkers Market by Application
5.2 Japan Neurological Biomarkers Market
5.2.1 Japan Neurological Biomarkers Market by Type
5.2.2 Japan Neurological Biomarkers Market by Application
5.3 India Neurological Biomarkers Market
5.3.1 India Neurological Biomarkers Market by Type
5.3.2 India Neurological Biomarkers Market by Application
5.4 Australia Neurological Biomarkers Market
5.4.1 Australia Neurological Biomarkers Market by Type
5.4.2 Australia Neurological Biomarkers Market by Application
5.5 South Korea Neurological Biomarkers Market
5.5.1 South Korea Neurological Biomarkers Market by Type
5.5.2 South Korea Neurological Biomarkers Market by Application
5.6 Singapore Neurological Biomarkers Market
5.6.1 Singapore Neurological Biomarkers Market by Type
5.6.2 Singapore Neurological Biomarkers Market by Application
5.7 Rest of Asia Pacific Neurological Biomarkers Market
5.7.1 Rest of Asia Pacific Neurological Biomarkers Market by Type
5.7.2 Rest of Asia Pacific Neurological Biomarkers Market by Application

Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bio-Rad laboratories, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 Merck Group
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.4 PerkinElmer, Inc.
6.4.1 Company Overview
6.4.1 Financial Analysis
6.4.2 Segmental and Regional Analysis
6.4.3 Research & Development Expense
6.5 Shimadzu Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.6 Thermo Fisher Scientific, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 BioMérieux S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expenses
6.8 Myriad Genetics, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expenses
6.9 Quanterix Corporation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
6.9.5 Recent strategies and developments:
6.9.5.1 Partnerships, Collaborations, and Agreements:
6.10. Neuro-Bio Ltd.
6.10.1 Company Overview

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities